Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Davis

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Journal of Neurosurgery|September 10, 2003
Regeneration of rat sciatic nerve across a LactoSorb bioresorbable conduit with interposed short-segment nerve graftsPaul C Francel, Kevin S Smith, F Alan Stevens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNAJonathan E Zuckerman, Ismael Gritli, Anthony Tolcher, et al.
Nucleic Acids Research|July 29, 2005
Functional polarity is introduced by Dicer processing of short substrate RNAsScott D Rose, Dong-Ho Kim, Mohammed Amarzguioui, et al.
Journal of Medicinal Chemistry|October 27, 2006
Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene deliveryJianjun Cheng, Ryan Zeidan, Swaroop Mishra, et al.
European Heart Journal|August 28, 2007
Urocortin 2 infusion in human heart failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2007
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAJeremy D Heidel, Zhongping Yu, Joanna Yi-Ching Liu, et al.
Clinical Science (London, England : 1979)|May 11, 2005
Effect of urocortin 1 infusion in humans with stable congestive cardiac failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.
Nature|March 23, 2010
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesMark E Davis, Jonathan E Zuckerman, Chung Hang J Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivoJeremy D Heidel, Joanna Yi-Ching Liu, Yun Yen, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal of Neurosurgery|September 10, 2003
Regeneration of rat sciatic nerve across a LactoSorb bioresorbable conduit with interposed short-segment nerve graftsPaul C Francel, Kevin S Smith, F Alan Stevens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNAJonathan E Zuckerman, Ismael Gritli, Anthony Tolcher, et al.
Nucleic Acids Research|July 29, 2005
Functional polarity is introduced by Dicer processing of short substrate RNAsScott D Rose, Dong-Ho Kim, Mohammed Amarzguioui, et al.
Journal of Medicinal Chemistry|October 27, 2006
Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene deliveryJianjun Cheng, Ryan Zeidan, Swaroop Mishra, et al.
European Heart Journal|August 28, 2007
Urocortin 2 infusion in human heart failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2007
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAJeremy D Heidel, Zhongping Yu, Joanna Yi-Ching Liu, et al.
Clinical Science (London, England : 1979)|May 11, 2005
Effect of urocortin 1 infusion in humans with stable congestive cardiac failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.
Nature|March 23, 2010
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesMark E Davis, Jonathan E Zuckerman, Chung Hang J Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivoJeremy D Heidel, Joanna Yi-Ching Liu, Yun Yen, et al.
Pageof 12